Cite
HARVARD Citation
Shimizu, H. et al. (2021). A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects. Clinical pharmacology in drug development. 10 (1), pp. 46-56. [Online].